Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: A multicentre case-control study

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 104, Issue 3, 1997, Pages 385-386

  Ikomi, Amaju A ^a   Singer, Albert ^b  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b WHITTINGTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GESTAGEN; MEDROXYPROGESTERONE ACETATE; MIFEPRISTONE;

DRUG EFFECT; ENDOMETRIUM; FEMALE; HUMAN; LETTER; PRIORITY JOURNAL; UTERUS MYOMA;

ANTINEOPLASTIC AGENTS, HORMONAL; CASE-CONTROL STUDIES; FEMALE; HUMANS; LEIOMYOMATOSIS; MEDROXYPROGESTERONE 17-ACETATE; MULTICENTER STUDIES; UTERINE NEOPLASMS;

EID: 0031051243     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1997.tb11479.x     Document Type: Letter

References (4)

1. Lumbiganon P, Rugpao S, Phandhu-fung S, Laopaiboon M, Vudhikamraksa N, Werawatakul Y. Protective effect of depot-med-roxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case-control study. Br J Obstet Gynaecol 1996; 103: 909–914.
2. Grant JM. Editor's Choice. Br J Obstet Gynaecol 1996; 103 (9): vii–viii.
3. Slade RJ, McCallum KA, Ellis JD. Endometrial resection after GNRH analogue therapy: a possible new treatment for fibromyomata. J Obstet Gynaecol (London) 1993; 13: 69–71.
4. Sivin I, Stem J. Health during prolonged use of levonorgestrel 20 mcg/d and the Copper Tcu 380 Ag intrauterine contraceptive devices: a multicenter study. Fertil Steril 1994; 61: 70–77.